ovary neoplasm

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer Trial in United States (NUV-868, Olaparib, Enzalutamide)

Recruiting
  • Advanced Solid Tumor
  • +26 more
  • Baltimore, Maryland
  • +3 more
Aug 1, 2022

Subjects Treated With Autologous T Cells Using Sleeping Beauty

Not yet recruiting
  • Gynecologic Cancer
  • +9 more
  • Neoantigen specific TCR-T cell drug product
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

Recruiting
  • Gynecologic Cancer
  • +11 more
  • Neoantigen specific TCR-T cell drug product
  • Aldesleukin (IL-2)
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Ovarian Cancer, Endometrial Cancer, Ovary Tumor Trial in Multiple Locations (Physician's choice according to patient's needs.)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Physician's choice according to patient's needs.
  • Multiple Locations, Germany
    Multiple sites all over Germany
Dec 1, 2021

Ovarian Cancer, Tumor, Ovarian, Ovarian Tumor Trial in Xi'an (chemo, targeted therapeutics, immunotherapy, IFRT, IMRT or SBRT)

Recruiting
  • Ovarian Cancer
  • +16 more
  • chemotherapy, targeted therapeutics, immunotherapy
  • IFRT, IMRT or SBRT
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Xi'an Jiao Tong University
Sep 25, 2021

Ovarian Cancer, Ovary Tumor, Ovarian Tumors Trial in Wuhan (HIPEC, CRS, IVCT)

Active, not recruiting
  • Ovarian Cancer
  • +5 more
  • HIPEC
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
May 28, 2020

Ovary Tumor, Surgery Trial (the New Tissue Containment System)

Not yet recruiting
  • Ovary Neoplasm
  • Surgery
  • the New Tissue Containment System
  • (no location specified)
May 24, 2020